The steep decline in oversight has stalled a number of new drug applications. The agency says it is trying to protect its employees but critics say inspectors should be considered essential workers and do their jobs.The steep decline in oversight has stalled a number of new drug applications. The agency says it is trying to protect its employees but critics say inspectors should be considered essential workers and do their jobs.Drugs (Pharmaceuticals), Shortages, Factories and Manufacturing, Medicine and Health, Food and Drug Administration, Bristol Myers Squibb Company, Mylan Inc, Spectrum Pharmaceuticals Inc, Nivagen, Biocon Biologics, your-feed-healthcareRead More
